跳至主要内容
临床试验/2023-508785-16-00
2023-508785-16-00招募中3 期

Efficacy of dexmedetomidine versus midazolam sedation on extubation time in mechanically ventilated preterm infants: a randomized controlled multicenter trial (DEXPRE)

Assistance Publique Hopitaux De Paris9 个研究点 分布在 1 个国家目标入组 380 人开始时间: 2024年8月23日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
380
试验地点
9
主要终点
Time-to-extubation after discontinuation of dexmedetomidine-based sedation versus discontinuation of midazolam-based sedation in very preterm neonates.

研究概览

简要总结

To compare the efficacy of dexmedetomidine-based sedation versus midazolam-based sedation in very preterm neonates.

入排标准

年龄范围
0 years 至 17 years(0-17 Years)
接受健康志愿者

入选标准

  • Patient admitted in NICU
  • Randomization criteria 2 : elective sedation (acceptable delay between the decision to sedate and the administration of the sedative agent),
  • Randomization criteria 3 : presence or plan of a venous access,
  • Randomization criteria 4 : no medical contraindication related to the administration of dexmedetomidine or midazolam,
  • Holder(s) of parental authority must sign the written or electronic informed consent
  • Holder(s) of parental authority must sign the written or electronic informed consent
  • Randomization criteria 5 : no concomitant use of curare agent
  • randomization criteria 6 : no previous extubation within 7 days
  • Randomization criteria 7 : no Clonidine treatment
  • randomisation criteria 7 : no hemodynamic instability
  • randomisation criteria 8 : no palliative care
  • Gestational age at birth < 32 weeks of gestation (WG),
  • Corrected gestational age <45 weeks of gestation (WG)
  • Randomization criteria 1 : indication for sedation in the context of invasive mechanical ventilation

排除标准

  • Polymalformative syndrome
  • Palliative care,
  • Inclusion in another clinical trial on medicinal products, clinical investigation protocol concerning a medical device or interventional protocol not concerning a health product.
  • Clonidine treatment
  • Parents who don't understand French

结局指标

主要结局

Time-to-extubation after discontinuation of dexmedetomidine-based sedation versus discontinuation of midazolam-based sedation in very preterm neonates.

Time-to-extubation after discontinuation of dexmedetomidine-based sedation versus discontinuation of midazolam-based sedation in very preterm neonates.

次要结局

  • Administration of opioid agents during the period of interest, i.e., from the start of treatment (DEX or midazolam) until extubation
  • Time (in hours) between start of sedation and achievement of a normal Comfort B score (ie. between 11 and 17).
  • Intubation rate at 24 hours after extubation.
  • Proportion of patients with at least one value of the Finnegan score > 8 from within 3 days after extubation.
  • Hemodynamic and respiratory adverse event from start of the sedation until 84 h after the sedative is stopped defined as: bradycardia, hemodynamic instability, desaturation <85% despite optimization of mechanical ventilation, reintubation
  • In-hospital mortality
  • Severe neonatal morbidity

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Dr Clément CHOLLAT

Scientific

Assistance Publique Hopitaux De Paris

研究点 (9)

Loading locations...

相似试验